Emergent BioSolutions 10K 2016 Annual report | EBS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Aberrant, absolute, accidental, adjunct, ADM, alleviate, Altimmune, anticholinesterase, Appendix, APVO, ascending, assert, atropine, Attached, autoinjector, Bailey, Bayview, begun, BESP, biotechnology, Cape, cartridge, Century, chloride, CODM, compensatory, complaint, context, Coral, counsel, counter, criterion, Crowe, deficiency, District, Dowd, Dr, duly, EBOL, employment, enriched, EUND, Exhibit, extraction, Extraordinary, fall, Fargo, fever, FILOV, fourth, fragmented, Geller, German, Harsanyi, Hauer, hemorrhagic, hereto, herewith, Homeland, horse, IBT, IgG, indemnify, indeterminate, insecticide, insider, Intergen, intraperiod, IRS, isolated, jeopardized, Jerome, Jr, Kathryn, Language, lawsuit, Marburg, MCM, Meridian, Ministry, misleading, Motion, Municipal, NASDAQ, Neglected, Nonstatutory, notified, notwithstanding, obidoxime, obiltoxaximab, omitted, organizational, orthopox, pilot, Plaintiff, poisoning, Police, pralidoxime, precluded, preserve, pretax, prevail, prioritization, promissory, PRV, purported, rapidly, realigned, referenced, regime, reinstate, reissued, representation, resell, residual, retention, Revocable, Richard, Ronald, Rudman, shareholder, Singapore, situation, Specimen, Sponn, Sudan, sulfate, Sullivan, sulphate, Sunrise, supplementary, symptomatic, taxpayer, Tecovirimat, thereto, thereunder, thereunto, transition, transitional, transitioned, Trobigard, TrobigardTM, Tropical, unallocated, undersigned, unrealizable, unsecured, vendor, vi, VIG, vigorously, voluntary, voucher, William, XBRL, Zaire, zika, Zoon, Zsolt

Removed: Abbott, abbvie, abnormally, absence, absorb, abuse, acre, acting, acute, ADAPTIR, ADAPTIRTM, adding, AG, aggressive, AlphaNine, Alprolix, American, AmerisourceBergen, Amgen, AMP, Antex, antigen, Apotex, Arzerra, ASP, augmented, autoimmune, BATTM, Baxter, Behring, bendamustine, beneficiary, Benefix, Biogen, BioPort, Bioscience, bioterrorist, Biotest, biowarfare, birth, bleeding, Boehringer, bone, borrowed, Bracco, built, cancer, Cardinal, carrier, categorized, ceased, ceiling, Cephalon, challenging, chemotherapy, chickenpox, child, children, chronic, clarified, clause, CLL, clotting, CMS, Coast, combat, commenced, commonly, community, complement, Concurrent, confer, consistency, Consortium, constructed, consuming, counted, counterterrorism, coupled, CSL, cutting, cycle, dba, dealing, deductible, deeply, depleting, destroyed, die, discovery, discrete, disproportionate, distinct, DVA, ease, Education, enforced, England, entitle, escalation, ESPP, exclusion, exclusively, female, fencing, financially, forma, formula, formulated, fraud, fraudulent, frequent, FSS, gas, Gayzva, Genentech, Genmab, Gilead, GmbH, handled, HDN, hemolytic, hemophilia, history, hospital, HPPD, HSBC, humanized, HyperHEP, Idec, Imbruvica, immunocompromised, ImmunoGen, improved, inappropriate, incidence, incident, incompatible, Indian, induce, industrial, inflation, Ingelheim, inherited, inhibitor, instituted, interface, invoiced, irreversible, ITP, Johnson, joint, Journal, Justice, kickback, knowingly, Kuwait, larger, launch, Leukemia, liver, Lymphocytic, lymphoma, managed, marrow, maternal, maximizing, McKesson, Medicaid, medically, Medicare, missing, modular, MonoNine, multinational, mustard, network, neutralization, newborn, noncontrolling, Nordisk, North, Novo, Nplate, obinutuzumab, offered, ordered, otlertuzumab, outpatient, Oxford, pain, participate, partner, patentable, penalty, penetration, percent, perimeter, pertaining, pharmacy, PHS, pivotal, platelet, PNC, pregnant, prepare, presenting, prevalence, pro, producing, proliferate, Promacta, prophylactic, protein, published, purpura, qualification, radiation, reach, Realty, rebate, recurrence, red, redeemed, referral, reinfection, relapsed, remuneration, renamed, renovation, reorganization, repaid, repay, reportable, reprioritization, restore, restored, retired, Rhophlac, Rituxan, rituximab, Roche, routine, SA, sBLA, science, scrutiny, Seattle, secret, selectively, serve, showed, side, Society, solicit, spontaneously, strength, strictly, sufficiency, surface, tangible, team, Teva, Therapex, thrombocytopenic, tolerated, toxic, transplant, transplantation, transportation, trauma, Treanda, Turkey, turnover, UK, uncontrolled, unnecessary, untreated, USA, validating, Vaxin, vector, violate, Washington, weapon, willingly, women, worldwide

Emergent BioSolutions (EBS) 10-K2016 FY Annual report

Content analysis